Pileri A.; Guglielmo A.; Patrizi A.; Casadei B.; Bertuzzi C.; Zinzani P.L.; Agostinelli C., Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides), «JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT», 2021, 19, pp. 99 - 102 [Scientific article]
Pileri, Alessandro; Guglielmo, Alba; Patrizi, Annalisa; Casadei, Beatrice; Bertuzzi, Clara; Zinzani, Pier Luigi; Agostinelli, Claudio, Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides), «JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT», 2021, 19, pp. 99 - 102 [Scientific article]
Opinto G.; Agostinelli C.; Ciavarella S.; Guarini A.; Maiorano E.; Ingravallo G., Hodgkin lymphoma: A special microenvironment, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, Article number: 4665 , pp. 4665 - 4665 [Scientific article]Open Access
Bertuzzi C.; Sabattini E.; Agostinelli C., Immune microenvironment features and dynamics in hodgkin lymphoma, «CANCERS», 2021, 13, Article number: 3634 , pp. 1 - 18 [Scientific article]Open Access
Ricci C.; Morandi L.; Ambrosi F.; Righi A.; Gibertoni D.; Maletta F.; Agostinelli C.; Corradini A.G.; Uccella S.; Asioli S.; Sessa F.; La Rosa S.; Papotti M.G.; Asioli S., Intron 4–5 hTERT DNA Hypermethylation in Merkel Cell Carcinoma: Frequency, Association with Other Clinico-pathological Features and Prognostic Relevance, «ENDOCRINE PATHOLOGY», 2021, 32, pp. 385 - 395 [Scientific article]Open Access
Pizzi M.; Agostinelli C.; Santoro L.; Sbaraglia M.; Bertuzzi C.; Dal Santo L.; Friziero A.; Piazza F.; Zinzani P.L.; Dei Tos A.P.; Sabattini E., Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: A word of caution, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2021, 106, pp. 737 - 739 [Scientific article]
Pizzi M.; Agostinelli C.; Santoro L.; Sbaraglia M.; Bertuzzi C.; Dal Santo L.; Friziero A.; Piazza F.; Zinzani P.L.; Dei Tos A.P.; Sabattini E., Lymph node core needle biopsy in lymphoproliferative disorders—Authors’ reply to Al-Abbadi and colleagues, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2021, 107, pp. 297 - 298 [Comment or similar]
Sabattini E.; Pizzi M.; Agostinelli C.; Bertuzzi C.; Sacchetti C.A.S.; Palandri F.; Gianelli U., Progression in Ph-chromosome-negative myeloproliferative neoplasms: An overview on pathologic issues and molecular determinants, «CANCERS», 2021, 13, Article number: 5531 , pp. 5531 - 5531 [Scientific article]Open Access
Mantoan B.; Genuardi E.; Ferrante M.; Starza I.D.; Ciabatti E.; Grassi S.; de Novi L.A.; Cavalli M.; Mannu C.; Gazzola A.; Bomben R.; Degan M.; Alessandria B.; Pott C.; Delfau-Larue M.-H.; Garcia-Sanz R.; Agostinelli C.; Gattei V.; Galimberti S.; Del Giudice I.; Gaidano G.; Ladetto M.; Ferrero S.; Drandi D., Quality assessment for PCR-based minimal residual disease in Lymphoma: 10 Years of cross-laboratory standardization process within the fondazione italiana linfomi MRD network, «HEMASPHERE», 2021, 5, pp. e639 - e639 [Scientific article]Open Access
Mascolo M.; Travaglino A.; Varricchio S.; Russo D.; Sabattini E.; Agostinelli C.; Bertuzzi C.; Baldo A.; Pileri A.; Picardi M.; Pane F.; Staibano S., Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides, «VIRCHOWS ARCHIV», 2021, 478, pp. 961 - 968 [Scientific article]Open Access
Pileri A.; Guglielmo A.; Grandi V.; Violetti S.A.; Fanoni D.; Fava P.; Agostinelli C.; Berti E.; Quaglino P.; Pimpinelli N., The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications, «CELLS», 2021, 10, Article number: 2780 , pp. 2780 - 2803 [Scientific article]Open Access
Alessandro Pileri , Claudio Agostinelli, Clara Bertuzzi, Vieri Grandi, Vincenza Maio, Irene Lastrucci, Marco Santucci, Nicola Pimpinelli, BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role, «FRONTIERS IN ONCOLOGY», 2020, 10, Article number: 662 , pp. 1 - 3 [Scientific article]Open Access
Laginestra M.A.; Cascione L.; Motta G.; Fuligni F.; Agostinelli C.; Rossi M.; Sapienza M.R.; Righi S.; Broccoli A.; Indio V.; Melle F.; Tabanelli V.; Calleri A.; Novero D.; Facchetti F.; Inghirami G.; Sabattini E.; Bertoni F.; Pileri S.A., Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8), «MODERN PATHOLOGY», 2020, 33, pp. 319 - 319 [Scientific article]Open Access
Pileri, A.; Guglielmo, A.; Agostinelli, C.; Evangelista, V.; Bertuzzi, C.; Alessandrini, A.; Bruni, F.; Starace, M.; Massi, A.; Broccoli, A.; Patrizi, A.; Zinzani, P. L.; Piraccini, B. M., Cutaneous adverse-events in patients treated with Ibrutinib, «DERMATOLOGIC THERAPY», 2020, 33, Article number: e14190 , pp. 1 - 7 [Scientific article]
Vaira V.; Gaudioso G.; Laginestra M.A.; Terrasi A.; Agostinelli C.; Bosari S.; Di Sabatino A.; Vanoli A.; Paulli M.; Ferrero S.; Roncoroni L.; Lombardo V.; Perera L.P.; Fabris S.; Vecchi M.; Pileri S.; Elli L., Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis, «CLINICAL SCIENCE», 2020, 134, pp. 1151 - 1166 [Scientific article]
